Skip to content

Investigation of safety and usefulness of 70 vol% ethanol emulsified formulation containing olive fruit oil in children.

Investigation of safety and usefulness of 70 vol% ethanol emulsified formulation containing olive fruit oil in children. - Investigation of safety and usefulness of 70 vol% ethanol emulsified formulation containing olive fruit oil in children.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050825
Enrollment
20
Registered
2023-04-13
Start date
2023-03-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

two-six years old children

Interventions

Use the test product at least 4 times a day for 4 weeks.

Sponsors

Sunstar Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Infants with no symptoms of severe inflammation, eczema, atopic dermatitis, etc. at the test site. (2) The child's guardian agrees to participate in the test. (3) The child's guardian must be able to fill out usage diaries and questionnaires. (4) Must be able to come to the clinic on the designated date of visit.

Exclusion criteria

Exclusion criteria: (1) Those who have a history of allergies to pharmaceuticals, quasi-drugs, or cosmetics, or those who have skin hypersensitivity. (2) Those who have allergic symptoms to the ingredients of the test product. (3) Subjects who are taking drugs that may affect the evaluation of this study, such as steroids and immunosuppressants. (4) Subjects using topical steroids or Protopic on the test site. (5) Subjects who are using pharmaceuticals, quasi-drugs, and cosmetic hand care external preparations that may affect the usefulness of the test product. However, only petroleum jelly can be used. (6) Those who are participating in other clinical studies at the start of this study, or those who plan to participate in other clinical studies during the study period. (7) Those who are judged to be inappropriate by the investigator.

Design outcomes

Primary

MeasureTime frame
After using the test product for 4 weeks, "erythema", "scaling/desquamation", "dryness", "hardening/keratinization", "cracks", "disappearance of skin markings", and "pruritus" on palms, backs of hands and fingers. is visually evaluated by a dermatologist to determine safety and usefulness.

Secondary

MeasureTime frame
Measurement of skin hydration and transepidermal water loss, stratum corneum evaluation.

Countries

Japan

Contacts

Public ContactTomomi Ayasu

Sunstar Inc. Health & Beauty Innovation R&D

tomomi.ayasu@jp.sunstar.com+81-80-9937-4090

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026